Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Philippidis

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Human Gene Therapy|May 16, 2022
Bluebird Bio Eliminating 30% of Staff in RestructuringAlex Philippidis
Human Gene Therapy|April 21, 2023
PASTE, Don't Cut: Genome Editing Tool Looks Beyond CRISPR and PrimeAlex Philippidis
Human Gene Therapy. Clinical Development|September 16, 2016
Gene Therapy BriefsAlex Philippidis
Human Gene Therapy|January 20, 2021
Eli Lilly Establishes Gene Therapy Program with $1B Purchase of PrevailAlex Philippidis
Human Gene Therapy. Clinical Development|September 6, 2019
Gene Therapy BriefsAlex Philippidis
Human Gene Therapy|September 22, 2011
Orphan drugs, big pharmaAlex Philippidis
Human Gene Therapy|July 17, 2014
Gene therapy briefsAlex Philippidis
Human Gene Therapy|July 24, 2013
Gene therapy briefsAlex Philippidis
Human Gene Therapy|March 31, 2026
FDA Issues Plausible Mechanism Pathway Draft GuidanceAlex Philippidis
Human Gene Therapy|February 2, 2026
FDA Officials Outline "Plausible Mechanism" Pathway for Personalized TherapiesAlex Philippidis
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Human Gene Therapy|May 16, 2022
Bluebird Bio Eliminating 30% of Staff in RestructuringAlex Philippidis
Human Gene Therapy|April 21, 2023
PASTE, Don't Cut: Genome Editing Tool Looks Beyond CRISPR and PrimeAlex Philippidis
Human Gene Therapy. Clinical Development|September 16, 2016
Gene Therapy BriefsAlex Philippidis
Human Gene Therapy|January 20, 2021
Eli Lilly Establishes Gene Therapy Program with $1B Purchase of PrevailAlex Philippidis
Human Gene Therapy. Clinical Development|September 6, 2019
Gene Therapy BriefsAlex Philippidis
Human Gene Therapy|September 22, 2011
Orphan drugs, big pharmaAlex Philippidis
Human Gene Therapy|July 17, 2014
Gene therapy briefsAlex Philippidis
Human Gene Therapy|July 24, 2013
Gene therapy briefsAlex Philippidis
Human Gene Therapy|March 31, 2026
FDA Issues Plausible Mechanism Pathway Draft GuidanceAlex Philippidis
Human Gene Therapy|February 2, 2026
FDA Officials Outline "Plausible Mechanism" Pathway for Personalized TherapiesAlex Philippidis
Pageof 11